Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-07-024311
Filing Date
2007-05-11
Accepted
2007-05-11 08:22:41
Documents
10
Period of Report
2007-05-10

Document Format Files

Seq Description Document Type Size
1 v074599_6k.htm 6-K 17911
2 v074599_ex99-1.htm EX-99.1 1475
3 GRAPHIC v074599_ex99-1x1x1.jpg GRAPHIC 188763
4 GRAPHIC v074599_ex99-1x2x1.jpg GRAPHIC 151859
5 GRAPHIC v074599_ex99-1x3x1.jpg GRAPHIC 233702
6 GRAPHIC v074599_ex99-1x4x1.jpg GRAPHIC 132647
7 GRAPHIC v074599_ex99-1x5x1.jpg GRAPHIC 166578
8 GRAPHIC v074599_ex99-1x6x1.jpg GRAPHIC 169512
9 GRAPHIC v074599_ex99-1x7x1.jpg GRAPHIC 146491
10 GRAPHIC v074599_ex99-1x8x1.jpg GRAPHIC 306931
  Complete submission text file 0001144204-07-024311.txt   2083789
Mailing Address
Business Address LEVEL 1 100 DORCAS STREET SOUTH MELBOURNE VIC 3205 AUSTRALIA VICTORIA C3 00000 01161396908537
PRANA BIOTECHNOLOGY LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 07840171
SIC: 2834 Pharmaceutical Preparations